|
|||||||||||
![]() |
![]() |
||||||||||
Undergraduate Courses FALL COURSES
HCMG 101-001: HEALTH CARE SYSTEMS Tues, Thurs 12:00-1:30 pm Professor Dan Polsky SHDH 351 1 credit
This course introduces and examines the various components of the U.S. health care system. It will cover both private and public financing mechanisms, the forces of market competition and government regulation, and the impact of health policy on key stakeholders. While developing an understanding of the various parts of the U.S. health care system, students will also learn how to apply simple economic reasoning to examine health policy issues.
HCMG 202-401: THE ECONOMICS & FINANCING OF HEALTH CARE DELIVERY (Cross listed with ECON-039) Tues, Thurs 12:00-1:30 pm Professor Jonathan Kolstad SHDH 109 1 credit
The course provides an application of economic models to demand, supply, and their interaction in the medical economy. Influences on demand, especially health status, insurance coverage, and income will be analyzed. Physician decisions on the pricing and form of their own services, and on the advice they offer about other services, will be considered. Competition in medical care markets, especially for hospital services, will be studied. Special emphasis will be placed on government as demander of medical care services. Changes in Medicare payment and alternate forms of health reform are among the public policy issues to be addressed.
HCMG 204-401: COMPARATIVE HEALTH CARE SYSTEMS (Cross listed with HCMG 859-401) Mon, Wed 10:30 am-12:00 pm Professor Patricia Danzon Lauder Fisher Auditorium 1 credit
This course examines the structure of health care systems in different countries, focusing on financing, reimbursement, delivery systems and adoption of new technologies. We study the relative roles of private sector and public sector insurance and providers, and the effect of system design on cost, quality, efficiency and equity of medical services. Some issues we address are normative: Which systems and which public/private sector mixes are better at achieving efficiency and equity? Other issues are positive: How do these different systems deal with tough choices, such as decisions about new technologies? Our main focus is on the systems in four large OECD countries—Germany, Canada, Japan, and the United Kingdom—but we also look at other countries with interesting systems- including Italy, Chile, Singapore and developing countries including China and India. We will draw lessons for the U.S. from foreign experience and vice versa.
HCMG 211-401: LEGAL ASPECTS OF HEALTH CARE (Cross listed with HCMG 854-401) Tues, Thurs 1:30-3:00 pm Professor Arnold Rosoff Lecturer Robert Field Huntsman Hall G55 1 credit
This course offers a current and historical overview of the regulation of health care delivery in the U.S. It examines principles and practical applications of the laws that affect the operational decisions of health care providers, payors, and managers and that impact development of markets for health care products and services. Also considered are the social, moral, and ethical issues encountered in trying to balance the interests, needs and rights of individual citizens against those of society. Special attention will be given this year to the recent healthcare reform campaigns and the resulting legislation. For part of the term, the class will divide into two groups so that students can focus on their choice of (a) health care management or (b) selected issues of patients' rights.
HCMG 213-001: HEALTH CARE MANAGEMENT AND STRATEGY Mon, Wed 12:00-1:30 pm Lecturer Emi Terasawa Colonial Penn Center Auditorium 1 credit
This course presents an overview of the business of health and how a variety of health care organizations have gained, sustained, and lost competitive advantage amidst intense competition, widespread regulation, high interdependence, and massive technological, economic, social, and political changes. Specifically, we evaluate the challenges facing health care organizations using competitive analysis, identify their past responses, and explore the current strategies they are using to manage these challenges (and emerging ones) more effectively. Students will develop generalized skills in competitive analysis and the ability to apply those skills in the specialized analysis of opportunities in producer (e.g. biopharmaceutical, medical product, information technology), purchaser (e.g. insurance), and provider (e.g. hospitals, nursing homes, physician) organizations and industry sectors. The course is organized around a number of readings, cases, presentations, and a required project.
SPRING COURSES
HCMG 101-001: HEALTH CARE SYSTEMS Tues, Thurs 12:00-1:30 pm Professor Scott Harrington Steinberg Hall - Dietrich Hall 350 1 credit
This course introduces and examines the various components of the U.S. health care system. It will cover both private and public financing mechanisms, the forces of market competition and government regulation, and the impact of health policy on key stakeholders. While developing an understanding of the various parts of the U.S. health care system, students will also learn how to apply simple economic reasoning to examine health policy issues.
HCMG 203-001: CLINICAL ISSUES IN HEALTH CARE MANAGEMENT: DOCTORS, PATIENTS AND MANAGERS IN MODERN SOCIETY Mon, Wed 3:00-4:30 pm Huntsman Hall G-55 1 credit
HCMG 212-001: HEALTH CARE QUALITY AND OUTCOMES: MEASUREMENT AND MANAGEMENT Tues, Thurs 3:00-4:30 pm Professor Jeffrey H. Silber Colonial Penn Center Auditorium 1 credit Prerequisite: Introductory Statistics or Permission of Instructor
This course will familiarize students with methods used to assess the quality of hospital or provider health care using outcomes data, and to understand and evaluate studies involving health care outcomes. Students are exposed to the mechanics of hospital quality evaluation and challenged to evaluate the medical and health services research literature on health care evaluation, as well as to make inferences regarding hospital quality and the comparison or rankings of hospitals or providers. Topics will include the history of health care outcomes analysis; the conceptual framework for outcomes studies; consumer demand for information; an overview of medical data and data collection systems; a description of outcome statistics and severity adjustments currently in use; the study of excess variation in outcomes; and the use of guidelines to assess outcomes. By the end of the course, students will have developed a thorough appreciation of the current methods used by policy makers, researchers, and health care providers to evaluate medical outcomes, as well as those used by consumers to choose hospitals and providers.
Mon, Wed 12:00 -1:30 Huntsman Hall 340 Prerequisite: One undergraduate Health Care course or one Economics course or equivalent experience with permission of instructor
This course provides an overview of the management, economic and policy issues facing the pharmaceutical, biotechnology, and medical device industries. The course perspective is global, but with emphasis on the U.S. as the largest and most profitable market. Critical issues we will examine include: R&D intensive cost structure and rapid technological change; biotechnology and genomics startups and alliances with the pharma industry; a complex global marketplace in which prices are regulated in most countries and customers include governments and insurers, as well as physicians, pharmacists and consumers; intense and evolving M&A, including mergers, joint ventures, and complex alliances; government regulation of every business function, including R&D, pricing and promotion; and global products and multinational firms. We use Wharton and industry experts from various disciplines to address these issues.
(Cross listed with ECON 236) Tues, Thurs 1:30-3:00 pm Huntsman Hall F-85 1 credit
* Pre-requisites for HCMG 302-401: ECON 1 & ECON 2 OR BPUB 250 Students who take HCMG 302 (ECON 236) may not also take HCMG 202 (ECON 039) for further credit
This course provides an application of economic principles to the health care sector. By recognizing the importance of scarcity and incentives this course will focus on the critical economic issues in producing, delivering and financing health care. In particular, the course will analyze determinants of demand for medical care, such as health status, insurance coverage, and income; the unique role of physicians in guiding and shaping the allocation of resources in medical care markets; and competition in medical care markets, especially among hospitals. Special emphasis will be placed on the evaluation of policy instruments such as government regulation, antitrust laws, 'sin taxes' on ciigarettes and alcohol, and public health programs. The course will use more advanced quantitative methods and formal economic theory; knowledge of calculus and basic microeconomics are recommended.
|
|
||||||||||
| ABOUT THIS SITE || UNIVERSITY OF PENNSYLVANIA (c) 2010 | |||||||||||